Abiopharma

🔍 Herrington Douglas J (Executive)

Company: AMAZON COM INC (AMZN)

Report Date: 2026-08-21

Detailed Transactions and Holdings:

• Acquired 7,500 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 474,638.00 | transaction_form_type: 4
• Acquired 2,840 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 477,478.00 | transaction_form_type: 4
• Acquired 5,565 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 483,043.00 | transaction_form_type: 4
• Sold 1,825 shares of Common Stock, par value $.01 per share at $257.7656 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 481,218.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,125 shares of Common Stock, par value $.01 per share at $258.5805 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 479,093.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,412 shares of Common Stock, par value $.01 per share at $260.3251 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 476,681.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Holds 0 shares of Common Stock, par value $.01 per share (Direct)
  Date: 2026-08-21 | Code: H | nature_of_ownership: Amazon.com 401(k) plan account | shares_owned_after: 6,609.35
• Sold 7,500 shares of Restricted Stock Unit Award (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2027-02-21 | Exercise: 2023-05-21 | equity_swap_involved: 0 | shares_owned_after: 15,000.00 | transaction_form_type: 4 | Footnotes: F5, F6
• Sold 2,840 shares of Restricted Stock Unit Award (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2028-02-21 | Exercise: 2024-05-21 | equity_swap_involved: 0 | shares_owned_after: 37,540.00 | transaction_form_type: 4 | Footnotes: F5, F7
• Sold 5,565 shares of Restricted Stock Unit Award (Derivative)
  Date: 2026-08-21 | Code: M | Expires: 2030-02-21 | Exercise: 2025-05-21 | equity_swap_involved: 0 | shares_owned_after: 159,855.00 | transaction_form_type: 4 | Footnotes: F5, F8

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2025.
• F2: Represents the weighted average sale price. The highest price at which shares were sold was $258.11 and the lowest price at which shares were sold was $257.19.
• F3: Represents the weighted average sale price. The highest price at which shares were sold was $258.98 and the lowest price at which shares were sold was $258.23.
• F4: Represents the weighted average sale price. The highest price at which shares were sold was $261.00 and the lowest price at which shares were sold was $260.03.
• F5: Converts into Common Stock on a one-for-one basis.
• F6: This award vests based upon the following vesting schedule: 7,500 shares on each of May 21, 2023, August 21, 2023, November 21, 2023, February 21, 2024, May 21, 2026, August 21, 2026, November 21, 2026, and February 21, 2027.
• F7: This award vests based upon the following vesting schedule: 2,600 shares on each of May 21, 2024, August 21, 2024, November 21, 2024, and February 21, 2025; 3,520 shares on May 21, 2025; 3,500 shares on each of August 21, 2025, November 21, 2025, and February 21, 2026; 2,860 shares on May 21, 2026; 2,840 shares on each of August 21, 2026, November 21, 2026, and February 21, 2027; 7,980 shares on May 21, 2027; and 7,960 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028.
• F8: This award vests based upon the following vesting schedule: 3,827 shares on each of May 21, 2025, August 21, 2025, November 21, 2025, and February 21, 2026; 5,565 shares on each of May 21, 2026, August 21, 2026, and November 21, 2026; 5,564 shares on February 21, 2027; 6,785 shares on May 21, 2027; 6,784 shares on each of August 21, 2027, November 21, 2027, and February 21, 2028; 17,162 shares on each of May 21, 2028 and August 21, 2028; 17,161 shares on each of November 21, 2028 and February 21, 2029; 13,236 shares on each of May 21, 2029, August 21, 2029, and November 21, 2029; and 13,235 shares on February 21, 2030.
• REMARKS: The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.